Keelo, Rihab Mudhafar Ali HammoodElbe, HulyaBicer, YaseminYigitturk, GurkanKoca, OguzhanKarayakali, MelikeAcar, Derya2024-09-292024-09-2920220009-27971872-7786https://doi.org/10.1016/j.cbi.2021.109733https://hdl.handle.net/20.500.14619/4459One of the most common complications of diabetes is diabetic nephropathy (DN). Uncontrolled hyperglycemia leads to histopathologic alterations in the kidney that prevent normal renal function. This study aimed to explore the effects of crocin treatment via virtue of its numerous beneficial properties in streptozotocin-induced pinealectomized diabetic rats. The pinealectomy procedure was conducted on the first day of the study. On the 30th day following pinealectomy, streptozotocin (STZ) (50 mg/kg) was administered intraperitoneally in Wistar rats for induction of diabetes. Diabetes was confirmed on the 3rd day following STZ administration by determining the glucose levels. Daily crocin treatment intraperitoneally for 15 days (50 mg/kg) ameliorated impaired renal oxidant/antioxidant balance, reduced TGF-81 immuno-staining around tubules, and promoted improvement of renal architecture. Moreover, crocin administration improved altered renal function parameters, including serum Cr and BUN, and also increased creatinine clearance. In conclusion, the protective effects of crocin on diabetic nephropathy might be associated with its powerful antioxidant properties, its ability to improve tissue antioxidant status, and its ability to prevent inflammatory pathways.eninfo:eu-repo/semantics/closedAccessPinealectomyDiabetesCrocinMDATGF-81ROSArticle10.1016/j.cbi.2021.1097332-s2.0-85118331319Q1351WOS:000721106500005Q1